Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Research and Development Grants

University of Guelph

$33,750.00

Identification of commensal lactobacilli with immunomodulatory activities and inhibitory effects on Salmonella colonization in chickens

EF 2011-12

Résumé
Lactic acid producing bacteria (LAB) are a group of microbes that can be found in the intestines of mammals and avian species. Several LAB, including lactobacilli have been found to have probiotic activities. Some lactobacilli are normal members of the intestinal community of microbes and confer upon their host health benefits. These health benefits include control of disease-causing enteric microbes and enhancement of host immune response, both systemically and also locally in the intestine. In the poultry industry, some practices, such as the prophylactic use of antibiotics, alter the composition of the intestinal microbial community and may limit the ability of commensal microbes to control disease-causing microbes, such as Salmonella. In fact, poultry products are a major source of food-borne disease for humans. In Canada, Salmonella caused about 5,200 reported cases of food-borne illness in 2004, with an average estimated cost of $1,100.00 per reported case in 2001-02. It should also be noted that based on some estimates, the number of unreported cases of salmonellosis is 10 times higher than the number of reported cases. Therefore, it has become urgent for the poultry industry to develop strategies for control of transmission of food-borne pathoegens from poultry to humans. Probiotics containing lactobacilli offer one such strategy. In addition to the effects of probiotics on control of enteric pathogens, lactobacilli possess immunomodulatory activities in chickens. However, the immune enhancing mechanisms of probiotics in the chicken have not been studied in depth. More importantly, a very limited number of probiotic products are currently available with proven immune enhancing capabilities in chickens. Therefore, the proposed studies are aimed to screen commensal lactobacilli present in the chicken gut microbiota to identify isolates that have superior immunomodulatory activities. Furthermore, we intend to assess the efficacy of these bacteria either alone or in combination in reducing colonization of the chicken gut by Salmonella.
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
399603-2010
Name nom
Sharif, Shayan
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2010
Award amount
33750
Program id
CRDPJ
Program nane en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Partie
2
Nb partie
2
Application title
Identification of commensal lactobacilli with immunomodulatory activities and inhibitory effects on Salmonella colonization in chickens
Keyword
NSERC
Application summary
Lactic acid producing bacteria (LAB) are a group of microbes that can be found in the intestines of mammals and avian species. Several LAB, including lactobacilli have been found to have probiotic activities. Some lactobacilli are normal members of the intestinal community of microbes and confer upon their host health benefits. These health benefits include control of disease-causing enteric microbes and enhancement of host immune response, both systemically and also locally in the intestine. In the poultry industry, some practices, such as the prophylactic use of antibiotics, alter the composition of the intestinal microbial community and may limit the ability of commensal microbes to control disease-causing microbes, such as Salmonella. In fact, poultry products are a major source of food-borne disease for humans. In Canada, Salmonella caused about 5,200 reported cases of food-borne illness in 2004, with an average estimated cost of $1,100.00 per reported case in 2001-02. It should also be noted that based on some estimates, the number of unreported cases of salmonellosis is 10 times higher than the number of reported cases. Therefore, it has become urgent for the poultry industry to develop strategies for control of transmission of food-borne pathoegens from poultry to humans. Probiotics containing lactobacilli offer one such strategy. In addition to the effects of probiotics on control of enteric pathogens, lactobacilli possess immunomodulatory activities in chickens. However, the immune enhancing mechanisms of probiotics in the chicken have not been studied in depth. More importantly, a very limited number of probiotic products are currently available with proven immune enhancing capabilities in chickens. Therefore, the proposed studies are aimed to screen commensal lactobacilli present in the chicken gut microbiota to identify isolates that have superior immunomodulatory activities. Furthermore, we intend to assess the efficacy of these bacteria either alone or in combination in reducing colonization of the chicken gut by Salmonella.